Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Identification of a novel compound that reduces mortality from severe influenza and elucidation of its molecular mechanisms

FY 2018-19

Summary
The influenza virus causes hundreds of thousands of deaths annually worldwide. There is a constant threat of a novel strain developing, leading to an influenza pandemic. While antivirals exist for the treatment of infections, the virus changes quickly and cases of resistance to these drugs have already occurred. As such, novel therapeutics for the treatment of influenza are urgently needed. Recent findings have shown that the host body’s response to infection can be damaging and cause death. Consequently, drugs that alter the body’s response to the virus, instead of directly targeting the virus, may be useful for the treatment of influenza. We have identified a drug that protects both zebrafish and mice from death due to influenza infection. So far, our studies show that the drug does not seem to repress the virus itself, which means it should not lead to viral resistance. Rather, it seems that the drug is improving how the body responds to the virus. This project is designed to figure out specifically how the drug works at the level of cells and molecules, so it can be developed to use for the treatment of influenza patients. To do this, we will use sophisticated molecular biology techniques and computer-aided analysis to identify the target of the drug.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406543
Name
Latreille Elyse
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of a novel compound that reduces mortality from severe influenza and elucidation of its molecular mechanisms
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Endothelial Activation; Influenza; Innate Immunity; Intercellular Adhesion Molecule 1; Lung Injury
Abstract
The influenza virus causes hundreds of thousands of deaths annually worldwide. There is a constant threat of a novel strain developing, leading to an influenza pandemic. While antivirals exist for the treatment of infections, the virus changes quickly and cases of resistance to these drugs have already occurred. As such, novel therapeutics for the treatment of influenza are urgently needed. Recent findings have shown that the host body’s response to infection can be damaging and cause death. Consequently, drugs that alter the body’s response to the virus, instead of directly targeting the virus, may be useful for the treatment of influenza. We have identified a drug that protects both zebrafish and mice from death due to influenza infection. So far, our studies show that the drug does not seem to repress the virus itself, which means it should not lead to viral resistance. Rather, it seems that the drug is improving how the body responds to the virus. This project is designed to figure out specifically how the drug works at the level of cells and molecules, so it can be developed to use for the treatment of influenza patients. To do this, we will use sophisticated molecular biology techniques and computer-aided analysis to identify the target of the drug.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Latreille, Elyse
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~